🇨🇦 leuprorelin acetate 3.75mg in Canada

leuprorelin acetate 3.75mg (leuprorelin acetate 3.75mg) regulatory status in Canada.

Marketing authorisation

leuprorelin acetate 3.75mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is leuprorelin acetate 3.75mg approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for leuprorelin acetate 3.75mg in Canada?

Peptron, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.